HealthQuill migraines
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed to rope in a partner to cut costs of obtaining standard regulatory approval.
Climate Health Medical

Climate change impacting migraine frequency and intensity

HQ Team May 16, 2024: Migraine is a debilitating condition that affects people both mentally and physically. Recent statistics show that the frequency.

Read More
X